… Over the course of a decade, the included trials evaluated the drug sacubitril/valsartan against
a control drug to check for its efficacy, safety, and treatment modality to ensure HF patients …

… , this real-world study in Asian patients with essential hypertension with and without comorbidities,
demonstrated the efficacy and safety of once daily nebivolol, either as monotherapy or …

… tolerance to sacubitril/valsartan. In this analysis, relatively few patients who developed moderate
… also developed moderate eGFR decline on transition to sacubitril/valsartan. Moreover, …

… We compared the efficacy and safety of third-standard-dose triple and third-standard-dose
dual antihypertensive combination therapies in patients with mild to moderate hypertension. …

… effectiveness of valsartan (Val)-based SPC therapies in achieving BP control in hypertensive
patients… The use of VAL-based SPC therapies in our study also showed good tolerability, …

… Additionally, we explore the latest developments and emerging evidence on the efficacy,
safety, and clinical outcomes of common and novel drug treatments in the management of …

… The purpose of this study was to evaluate the efficacy and safety of the fimasartan,
amlodipine, and rosuvastatin combination therapy in patients with essential hypertension and …

… This study will perform a network meta-analysis to assess the efficacy and safety of different
… efficacy and safety of different doses of azilsartan medoxomil in patients with hypertension. …

… effectiveness and safety of both triple fixed-dose combinations containing Per/Aml/Ind and
Tel/ Aml/Chl from the outpatient database of treatment-naïve grade 2 hypertensive patients …

… a continuum of use in the patient’s journey with HFrEF. This article summarises available
data on the effectiveness and tolerability of sacubitril/valsartan in patients with HFrEF, and …